WuXi AppTec Co., Ltd. Class H (HK:2359) has released an update.
WuXi AppTec Co., Ltd. has announced its unaudited interim financial results, revealing a year-over-year revenue decrease of 8.6% for the first half of 2024, with a more significant drop of 20.2% in net profit attributable to company owners. Despite the declines, the company, a global provider of R&D and manufacturing services to the pharmaceutical and life sciences industries, continues its commitment to delivering efficient and cost-effective solutions for healthcare product advancement.
For further insights into HK:2359 stock, check out TipRanks’ Stock Analysis page.
